Experimental Treatment for Recurrent Respiratory Papillomatosis Earns Orphan Drug Designation
source: pixabay.com

Experimental Treatment for Recurrent Respiratory Papillomatosis Earns Orphan Drug Designation

According to a story from PR Newswire, the biotechnology company INOVIO has just announced that the company's investigational product candidate INO-3107 has earned Orphan Drug designation from the US Food…

Continue Reading Experimental Treatment for Recurrent Respiratory Papillomatosis Earns Orphan Drug Designation
The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?
source: pixabay.com

The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?

According to a story from Youth Today, the Americans with Disabilities Act (ADA) was first passed 30 years ago, in 1990. This historic law helps protect people that live with…

Continue Reading The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?
Juvenile Arthritis Awareness Month: Teen Living with Juvenile Idiopathic Arthritis Isn’t Slowing Down
source: pixabay.com

Juvenile Arthritis Awareness Month: Teen Living with Juvenile Idiopathic Arthritis Isn’t Slowing Down

According to a story from gopresstimes.com, Lily Laurent, a 13 year old student at De Pere middle school in Wisconsin, has lived with juvenile idiopathic arthritis for nine years. While…

Continue Reading Juvenile Arthritis Awareness Month: Teen Living with Juvenile Idiopathic Arthritis Isn’t Slowing Down
Traveling with Atypical Hemolytic Uremic Syndrome: Tips for Patients
source: pixabay.com

Traveling with Atypical Hemolytic Uremic Syndrome: Tips for Patients

According to a story from ahusnews.com, traveling with atypical hemolytic uremic syndrome (aHUS) takes some extra preparation and planning ahead. This syndrome can affect multiple organ systems and especially the…

Continue Reading Traveling with Atypical Hemolytic Uremic Syndrome: Tips for Patients
Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising
source: pixabay.com

Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising

According to a story from BioSpace, the biopharmaceutical company Bioniz Therapeutics, Inc., has recently announced the release of interim results from its phase 1/2 clinical trial. This trial is investigating…

Continue Reading Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising
Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
source: pixabay.com

Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation

According to a story from BioSpace, the biotechnology company Ascentage Pharma has just announced that it has been given Orphan Drug designation from the US Food and Drug Administration (FDA).…

Continue Reading Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
Problems with Eyesight Prevalent in Parkinson’s Disease as Patients Age, Study Finds
source: pixabay.com

Problems with Eyesight Prevalent in Parkinson’s Disease as Patients Age, Study Finds

According to a story from Parkinson's News Today, older patients with Parkinson's disease appear to have a higher than average rates of vision problems. These issues are also associated with…

Continue Reading Problems with Eyesight Prevalent in Parkinson’s Disease as Patients Age, Study Finds
Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available
source: pixabay.com

Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

According to a story from Physician's Weekly, while measuring the concentration of albumin (albuminuria) is widely considered the standard method for staging and screening for chronic kidney disease, a different…

Continue Reading Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available